Eledon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 146.9%.

Top 25 shareholders own 42.79% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.5%	BVF Partners L.P.	6,293,282	€25.3m	0%	0.73%
5.97%	RA Capital Management, L.P.	3,566,338	€14.3m	0%	0.17%
5.96%	Frazier Life Sciences Management, LP	3,561,644	€14.3m	0%	0.57%
3.96%	Armistice Capital LLC	2,364,000	€9.5m	1.2%	0.24%
2.62%	The Vanguard Group, Inc.	1,565,487	€6.3m	41.8%	no data
2.51%	Schonfeld Strategic Advisors LLC	1,500,000	€6.0m	0%	0.05%
2.4%	Zimmer Partners, LP	1,434,727	€5.8m	-32%	0.1%
2.17%	Sphera Funds Management Ltd	1,297,321	€5.2m	0.02%	0.9%
1.41%	Woodline Partners LP	842,892	€3.4m	24.8%	0.03%
1%	Nantahala Capital Management, LLC	600,000	€2.4m	0%	0.17%
0.84%	Alyeska Investment Group, L.P.	500,000	€2.0m	0%	0.01%
0.74%	Ensign Peak Advisors, Inc.	443,001	€1.8m	0%	no data
0.63%	Geode Capital Management, LLC	378,058	€1.5m	9.74%	no data
0.46%	CM Management, LLC	275,000	€1.1m	71.9%	0.86%
0.36%	BlackRock, Inc.	215,868	€868.4k	39.2%	no data
0.27%	State Street Global Advisors, Inc.	161,492	€649.6k	0%	no data
0.23%	Renaissance Technologies LLC	135,873	€546.6k	-0.66%	no data
0.15%	Northern Trust Global Investments	91,893	€369.6k	0%	no data
0.14%	Morgan Stanley, Investment Banking and Brokerage Investments	83,471	€335.8k	3,770%	no data
0.097%	JMAC Enterprises LLC	58,041	€233.5k	0%	0.04%
0.087%	Ingalls & Snyder, LLC	51,849	€208.6k	0%	0.01%
0.075%	Next Edge Capital Corp.	45,000	€181.0k	0%	0.71%
0.057%	Dimensional Fund Advisors LP	34,223	€137.7k	13.2%	no data
0.056%	Bridgeway Capital Management, LLC	33,400	€134.4k	0%	no data
0.051%	Marco Investment Management, LLC	30,344	€122.1k	0%	0.01%